Chemomab Therapeutics Ltd. (CMMB)

NCM – Real Time Price. Currency in USD

1.88

-0.03 (-1.57%)

Market open: Aug 12, 2026, 12:26 PM EDT

1.90

-0.01 (-0.52%)

Previous after-hours: Aug 11, 2026, 4:04 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-71K

-53K

-67K

-58K

Gross Profit

-71K

-53K

-67K

-58K

Operating expenses (excl. COGS)

-10M

-15M

-25M

-28M

Operating Income

-10M

-15M

-25M

-28M

Non-operating income, total

577K

798K

352K

Pretax income

-9M

-14M

-24M

-28M

Equity in earnings

Taxes

532K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-9M

-14M

-24M

-28M

Discontinued operations

Net income

-9M

-14M

-24M

-28M

Dilution adjustment

Preferred dividends

Chemomab Therapeutics Ltd. (CMMB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Chemomab Therapeutics Ltd. (CMMB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Chemomab Therapeutics Ltd. (CMMB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Chemomab Therapeutics Ltd. (CMMB)

Income Statement (Annual)

Income Statement (Annual)